Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

China Biotech Week in Review: New Deals in China Life Science
Seeking Alpha
Sunday, February 28, 2010 - 1:02pm
tags:
China, biotech
Battle Brews for Control of Genzyme
Seeking Alpha
Sunday, February 28, 2010 - 12:43pm
tags:
Genzyme
Adamis Pharma signs pact to acquire prostate cancer drug candidates from Colby Pharma
Pharmabiz
Saturday, February 27, 2010 - 1:23pm
tags:
Adamis Pharmaceuticals, prostate cancer
Genta starts phase-2 trial of oncology product Tesetaxal
Pharmabiz
Saturday, February 27, 2010 - 1:17pm
tags:
Genta, Tesetaxel, cancer, tubulin inhibitor
Forest Laboratories Receives Decision From FDA For Supplemental New Drug Application For Bystolic(R)
Medical News Today
Saturday, February 27, 2010 - 12:44pm
tags:
Forrest, Bystolic, heart failure
U.S. Food And Drug Administration Approves Cayston(R) For The Improvement Of Respiratory Symptoms In Cystic Fibrosis Patients
Medical News Today
Saturday, February 27, 2010 - 12:42pm
tags:
Gilead Sciences, Cayston, cystic fibrosis
Roche says Avastin phase III study shows positive results in women with advanced ovarian cancer
Pharnabiz
Saturday, February 27, 2010 - 12:34pm
tags:
Roche, Avastin, ovarian cancer
Abbott's Estimates on the Rise
Yahoo/Zacks
Saturday, February 27, 2010 - 12:15pm
tags:
Abbott Laboratories
Drug Company Cost Cuts: Careful What You Wish For
Motley Fool
Saturday, February 27, 2010 - 12:13pm
tags:
Boning Up on Pfizer's Drug
Forbes
Saturday, February 27, 2010 - 12:12pm
tags:
Fablyn, Pfizer, Eli Lilly, Evista, osteoporosis
Novartis Eyes Smaller-Than-Alcon Deals; Holders Okay ‘Say on Pay’
WSJ
Saturday, February 27, 2010 - 11:48am
tags:
Novartis, M&A
Stroke study finds neck stents safe, effective
Yahoo/AP
Saturday, February 27, 2010 - 11:32am
tags:
stents
Lilly, Covance add biotech drugs to research deal
Yahoo/AP
Saturday, February 27, 2010 - 11:31am
tags:
Eli Lilly, Covance
Chelsea Therapeutics to Raise $18.2 Million in Registered Direct Offering
Yahoo/Global NewsWire
Saturday, February 27, 2010 - 11:29am
tags:
Chelsea Therapeutics
FDA approves Shire drug for Gaucher disease
Yahoo/AP
Saturday, February 27, 2010 - 11:27am
tags:
Shire, Gaucher disease, velaglucerase alfa
Vion Pharmaceuticals Receives Response From FDA on Special Protocol Assessment for Onrigin(TM)
Yahoo/PR NewsWire
Saturday, February 27, 2010 - 11:25am
tags:
Vion Pharmaceuticals
Savient posts smaller loss due to warrant gain
Yahoo/AP
Saturday, February 27, 2010 - 11:24am
tags:
Savient
Drug stocks inch higher; Cleveland BioLabs sinks
MarketWatch
Saturday, February 27, 2010 - 11:23am
tags:
biotech, Cleveland BioLabs
Our Top Five Biotech Takeout Picks
Morningstar
Saturday, February 27, 2010 - 11:21am
tags:
M&A, Vertex Pharmaceuticals, Auxilium, Human Genome Sciences, InterMune
Hope For Muscular Dystrophy Patients?
Forbes
Saturday, February 27, 2010 - 11:13am
tags:
Duchenne Muscular Dystrophy, PTC Therapeutics, Genentech, ataluren

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.